Correlation Between Praxis Precision and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Praxis Precision and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Praxis Precision and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Praxis Precision Medicines and ZyVersa Therapeutics, you can compare the effects of market volatilities on Praxis Precision and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Praxis Precision with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Praxis Precision and ZyVersa Therapeutics.
Diversification Opportunities for Praxis Precision and ZyVersa Therapeutics
-0.79 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Praxis and ZyVersa is -0.79. Overlapping area represents the amount of risk that can be diversified away by holding Praxis Precision Medicines and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Praxis Precision is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Praxis Precision Medicines are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Praxis Precision i.e., Praxis Precision and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Praxis Precision and ZyVersa Therapeutics
Given the investment horizon of 90 days Praxis Precision Medicines is expected to generate 0.56 times more return on investment than ZyVersa Therapeutics. However, Praxis Precision Medicines is 1.78 times less risky than ZyVersa Therapeutics. It trades about 0.14 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 1,820 in Praxis Precision Medicines on August 26, 2024 and sell it today you would earn a total of 5,630 from holding Praxis Precision Medicines or generate 309.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Praxis Precision Medicines vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Praxis Precision Med |
| ZyVersa Therapeutics |
Praxis Precision and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Praxis Precision and ZyVersa Therapeutics
The main advantage of trading using opposite Praxis Precision and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Praxis Precision position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Praxis Precision vs. Molecular Partners AG | Praxis Precision vs. Mineralys Therapeutics, Common | Praxis Precision vs. AN2 Therapeutics | Praxis Precision vs. Pharvaris BV |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |